Table 2.
Variables | 45, X | Mosaicism | Mosaicism with SCA | SCA | Y chromosome material | P values |
---|---|---|---|---|---|---|
4–7 years | ||||||
N | 13 | 4 | 4 | 3 | 2 | |
Age | 4.92 ± 1.17 | 6.25 ± 1.50 | 6.25 ± 0.50 | 6.33 ± 0.58 | 5.50 ± 2.12 | 0.147 |
AMH (ng/ml) | 0.02 (0.02–0.03) | 1.13 (0.75–1.30) | 0.04 (0.04–0.05) | 0.02 (0.02–0.62) | 0.03 (0.02–0.04) | 0.009 |
LH (mIU/ml) | 0.07 (0.07–0.18) | 0.05 (0.03–0.07) | 0.14 (0.09–0.15) | 0.07 (0.07–0.08) | 0.08 (0.07–0.09) | 0.272 |
FSH (mIU/ml) | 12.60 (7.23–41.14) | 2.00 (1.07–5.99) | 16.00 (13.66–24.36) | 8.04 (5.00–9.06) | 9.10 (3.65–14.55) | 0.07 |
Ovarian ultrasonography | 0.007 | |||||
Ovarian dysplasia or unilateral ovarian visualization | 13 (100%) | 1 (25%) | 2 (50%) | 2 (66.7%) | 1 (50%) | |
Bilateral ovarian visualization | 0 (0%) | 3 (75%) | 2 (50%) | 1 (33.3%) | 1 (50%) | |
8∼17 | ||||||
N | 28 | 12 | 13 | 13 | 3 | |
Age | 12.39 ± 2.56 | 11.18 ± 2.93 | 11.00 ± 2.35 | 11.31 ± 3.01 | 10.67 ± 2.08 | 0.424 |
AMH (ng/ml) | 0.03 (0.02–0.07) | 0.70 (0.03–1.59) | 0.03 (0.02–0.04) | 0.03 (0.02–0.05) | 0.06 (0.02–0.10) | 0.346 |
LH (mIU/ml) | 11.21 (0.82–17.35) | 1.23 (0.20–27.81) | 7.89 (0.23–26.39) | 15.89 (0.48–19.04) | 2.84 (1.54–15.65) | 0.983 |
FSH (mIU/ml) | 55.18 (11.79–90.36) | 17.02 (2.92–82.97) | 64.09 (9.29–105.33) | 58.57 (20.50–94.18) | 23.90 (16.25–58.87) | 0.606 |
Ovarian ultrasonography | 0.619 | |||||
Ovarian dysplasia or unilateral ovarian visualization | 18 (64.3%) | 5 (41.7%) | 9 (69.2%) | 10 (76.9%) | 2 (66.7%) | |
Bilateral ovarian visualization | 10 (35.7%) | 7 (58.3%) | 4 (30.8%) | 3 (23.1%) | 1 (33.3%) | |
Spontaneous puberty | 0.032 | |||||
No | 22 (78.6%) | 5 (41.7%) | 11 (84.6%) | 12 (92.3%) | 2 (66.7%) | |
Yes | 6 (21.4%) | 7 (58.3%) | 2 (15.4%) | 1 (7.7%) | 1 (33.3%) |
Data are expressed as means ± SDs or as medians (25th–75th percentiles). FSH; follicle-stimulating hormone; LH: luteinizing hormone; AMH: Anti-Müllerian hormone. pmol/L = ng/mL ∗ 7.14.